Endovascular treatment of ischemic moyamoya disease
10.3760/cma.j.issn.1673-4165.2023.04.006
- VernacularTitle:缺血型烟雾病的血管内治疗
- Author:
Bingjie ZHENG
1
;
Jinbiao YAO
;
Huaizhang SHI
Author Information
1. 哈尔滨医科大学附属第一医院神经外科，哈尔滨 150001
- Keywords:
Moyamoya disease;
Brain ischemia;
Endovascular procedures;
Angioplasty, balloon;
Stents;
Treatment outcome
- From:
International Journal of Cerebrovascular Diseases
2023;31(4):271-274
- CountryChina
- Language:Chinese
-
Abstract:
Moyamoya disease is a relatively rare cerebrovascular disease. Extracranial and intracranial vascular bypass is the first choice for moyamoya disease. However, due to the risk of complications and symptoms recurrence after surgery, there is still some controversy about surgical treatment. In recent years, with the development of minimally invasive interventional technology, the endovascular treatment of atherosclerotic ischemic cerebrovascular disease has been widely carried out in the world. Some doctors are also beginning to try endovascular treatment of ischemic moyamoya disease, but its efficacy and safety are still unclear. This article reviews the endovascular treatment of ischemic moyamoya disease.
